Concepedia

Cleber C. Melo‐Filho

CC

Statistics

Publications

17

Citations

1K

H-Index

15

Active since

2014

Affiliations

University of North Carolina at Chapel Hill(Current)

Universidade Federal de Goiás

Odesа Polytechnic National University

National Center for Advancing Translational Sciences

Universidade Evangelica de Goiás

Cleber C. Melo‐Filho is an author at University of North Carolina at Chapel Hill specializing in drug discovery, pharmacy, and pharmacology.

ORCID

Publications per year

2014–2025

17

Publications

17

QSAR-Based Virtual Screening: Advances and Applications in Drug Discovery

Bruno J. Neves, Rodolpho C. Braga, Cleber C. Melo‐Filho et al. · Frontiers in Pharmacology · 2018 · 483 citations · Full text

, , +17

Discovery of New Anti-Schistosomal Hits by Integration of QSAR-Based Virtual Screening and High Content Screening

Bruno J. Neves, Rafael Ferreira Dantas, Mário Roberto Senger et al. · Journal of Medicinal Chemistry · 2016 · 87 citations · Full text

, , +17

QSAR Modeling of SARS‐CoV M <sup>pro</sup> Inhibitors Identifies Sufugolix, Cenicriviroc, Proglumetacin, and other Drugs as Candidates for Repurposing against SARS‐CoV‐2

Vinícius M. Alves, Tesia Bobrowski, Cleber C. Melo‐Filho et al. · Molecular Informatics · 2020 · 85 citations

, , +17

3D-QSAR Approaches in Drug Design: Perspectives to Generate Reliable CoMFA Models

Cleber C. Melo‐Filho, Rodolpho C. Braga, Carolina Horta Andrade · Current Computer - Aided Drug Design · 2014 · 60 citations

, , +14

QSAR-Driven Discovery of Novel Chemical Scaffolds Active against <i>Schistosoma mansoni</i>

Cleber C. Melo‐Filho, Rafael Ferreira Dantas, Rodolpho C. Braga et al. · Journal of Chemical Information and Modeling · 2016 · 53 citations · Full text

, , +17

1–5 of 17